Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29082

1.

Lymphedema after Breast Cancer Treatment.

Rockson SG.

N Engl J Med. 2018 Nov 15;379(20):1937-1944. doi: 10.1056/NEJMcp1803290. Review. No abstract available.

PMID:
30428297
2.

Prediction model of lymphovascular invasion based on clinicopathological factors in Chinese patients with invasive breast cancer.

Shen S, Wu G, Xiao G, Du R, Hu N, Xia X, Zhou H.

Medicine (Baltimore). 2018 Oct;97(43):e12973. doi: 10.1097/MD.0000000000012973.

3.

Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response.

Dong JM, Wang HX, Zhong XF, Xu K, Bian J, Feng Y, Chen L, Zhang L, Wang X, Ma DJ, Wang B.

Medicine (Baltimore). 2018 Oct;97(43):e12965. doi: 10.1097/MD.0000000000012965.

4.

Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer.

Lee SJ, Chung MS, Shin SJ, Choi YY.

Medicine (Baltimore). 2018 Oct;97(43):e12840. doi: 10.1097/MD.0000000000012840.

5.

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.

Zheng J, Cai S, Song H, Wang Y, Han X, Wu H, Gao Z, Qiu F.

Medicine (Baltimore). 2018 Nov;97(44):e13015. doi: 10.1097/MD.0000000000013015.

6.

Reference values of bioelectrical impedance analysis for detecting breast cancer-related lymphedema.

Jung M, Jeon JY, Yun GJ, Yang S, Kwon S, Seo YJ.

Medicine (Baltimore). 2018 Nov;97(44):e12945. doi: 10.1097/MD.0000000000012945.

7.

Gene Expression-Guided Adjuvant Chemotherapy in Breast Cancer.

McCaw ZR, Wei LJ, Kim DH.

N Engl J Med. 2018 Oct 25;379(17):1681. doi: 10.1056/NEJMc1810515. No abstract available.

PMID:
30358968
8.

Synchronized Pedaling with Martial Arts Improves Quality of Life of Women with Breast Cancer.

Navarro-Sanz A, Espejo-Reina A, Cerezo-Guzman MV, Fernandez-Ortega JF, Meza-Leiva H, Conejo-Tirado I, Santiago-Sanchez C.

Int J Sports Med. 2018 Dec;39(13):978-983. doi: 10.1055/a-0710-5260. Epub 2018 Oct 22.

PMID:
30347415
9.

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.

Turner NC, Slamon DJ, Ro J, Bondarenko I, Im SA, Masuda N, Colleoni M, DeMichele A, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, André F, Puyana Theall K, Huang X, Giorgetti C, Huang Bartlett C, Cristofanilli M.

N Engl J Med. 2018 Nov 15;379(20):1926-1936. doi: 10.1056/NEJMoa1810527. Epub 2018 Oct 20.

PMID:
30345905
10.

Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis.

Ding W, Li Z, Wang C, Dai J, Ruan G, Tu C.

Medicine (Baltimore). 2018 Oct;97(42):e12908. doi: 10.1097/MD.0000000000012908. Review.

11.

Diffuse optical spectroscopy for monitoring the responses of patients with breast cancer to neoadjuvant chemotherapy: A meta-analysis.

Liu YH, Xue LB, Yang YF, Zhao TJ, Bai Y, Zhang BY, Li J.

Medicine (Baltimore). 2018 Oct;97(41):e12683. doi: 10.1097/MD.0000000000012683.

12.

Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.

Olasehinde O, Alatise O, Arowolo O, Adisa A, Wuraola F, Boutin-Foster C, Lawal O, Kingham T.

J Surg Oncol. 2018 Nov;118(6):861-866. doi: 10.1002/jso.25215. Epub 2018 Oct 7.

PMID:
30293243
13.

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

Yang H, Zhou L, Wang S, Cao Y, Tong F, Liu P, Zhou B, Cheng L, Liu M, Liu H, Xie F, Guo J, Wang S, Peng Y.

Medicine (Baltimore). 2018 Oct;97(40):e12690. doi: 10.1097/MD.0000000000012690.

14.

Everolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging.

Dejust S, Morland D, Bruna-Muraille C, Eymard JC, Yazbek G, Savoye AM, Papathanassiou D.

Medicine (Baltimore). 2018 Oct;97(40):e12518. doi: 10.1097/MD.0000000000012518.

15.

Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.

Ding DC, Chen W, Wang JH, Lin SZ.

Medicine (Baltimore). 2018 Sep;97(39):e12608. doi: 10.1097/MD.0000000000012608.

16.

Problems to affect long-term survival for breast cancer patients: An observational study of subsequent lung/bronchus malignancies.

Liu J, Hu Z, Feng Y, Zeng S, Zhong M.

Medicine (Baltimore). 2018 Sep;97(39):e12603. doi: 10.1097/MD.0000000000012603.

17.

Effectiveness of a Self-Care Toolkit for Surgical Breast Cancer Patients in a Military Treatment Facility.

Stoerkel E, Bellanti D, Paat C, Peacock K, Aden J, Setlik R, Walter J, Inman A.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):916-925. doi: 10.1089/acm.2018.0069.

18.

A Randomized Study of Yoga for Fatigue and Quality of Life in Women with Breast Cancer Undergoing (Neo) Adjuvant Chemotherapy.

Jong MC, Boers I, Schouten van der Velden AP, Meij SV, Göker E, Timmer-Bonte ANJH, van Wietmarschen HA.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):942-953. doi: 10.1089/acm.2018.0191.

PMID:
30247961
19.

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.

Pelzer F, Tröger W, Nat DR.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.

20.

Predictive value of soluble ST-2 for changes of cardiac function and structure in breast cancer patients receiving chemotherapy.

Huang G, Zhai J, Huang X, Zheng D.

Medicine (Baltimore). 2018 Sep;97(38):e12447. doi: 10.1097/MD.0000000000012447.

Supplemental Content

Loading ...
Support Center